| Pharmacological characterization of designer cathinones in vitro LD Simmler, TA Buser, M Donzelli, Y Schramm, LH Dieu, J Huwyler, ... British journal of pharmacology 168 (2), 458-470, 2013 | 735 | 2013 |
| A renaissance in trace amines inspired by a novel GPCR family L Lindemann, MC Hoener Trends in pharmacological sciences 26 (5), 274-281, 2005 | 354 | 2005 |
| TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity FG Revel, JL Moreau, RR Gainetdinov, A Bradaia, TD Sotnikova, R Mory, ... Proceedings of the national academy of sciences 108 (20), 8485-8490, 2011 | 343 | 2011 |
| Trace amine-associated receptor 1 modulates dopaminergic activity L Lindemann, CA Meyer, K Jeanneau, A Bradaia, L Ozmen, ... Journal of Pharmacology and Experimental Therapeutics 324 (3), 948-956, 2008 | 338 | 2008 |
| Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors L Lindemann, M Ebeling, NA Kratochwil, JR Bunzow, DK Grandy, ... Genomics 85 (3), 372-385, 2005 | 317 | 2005 |
| Trace amines and their receptors RR Gainetdinov, MC Hoener, MD Berry Pharmacological reviews 70 (3), 549-620, 2018 | 300 | 2018 |
| Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens A Rickli, OD Moning, MC Hoener, ME Liechti European Neuropsychopharmacology 26 (8), 1327-1337, 2016 | 297 | 2016 |
| Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin, and DJ-1 in Caenorhabditis elegans R Ved, S Saha, B Westlund, C Perier, L Burnam, A Sluder, M Hoener, ... Journal of Biological Chemistry 280 (52), 42655-42668, 2005 | 297 | 2005 |
| A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight FG Revel, JL Moreau, B Pouzet, R Mory, A Bradaia, D Buchy, V Metzler, ... Molecular psychiatry 18 (5), 543-556, 2013 | 272 | 2013 |
| The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system A Bradaia, G Trube, H Stalder, RD Norcross, L Ozmen, JG Wettstein, ... Proceedings of the National Academy of Sciences 106 (47), 20081-20086, 2009 | 243 | 2009 |
| Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings E Braungart, M Gerlach, P Riederer, R Baumeister, MC Hoener Neurodegenerative Diseases 1 (4-5), 175-183, 2004 | 238 | 2004 |
| Monoamine transporter and receptor interaction profiles of a new series of designer cathinones LD Simmler, A Rickli, MC Hoener, ME Liechti Neuropharmacology 79, 152-160, 2014 | 232 | 2014 |
| Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones A Rickli, MC Hoener, ME Liechti European Neuropsychopharmacology 25 (3), 365-376, 2015 | 214 | 2015 |
| Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges MD Berry, RR Gainetdinov, MC Hoener, M Shahid Pharmacology & therapeutics 180, 161-180, 2017 | 208 | 2017 |
| The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, ... Clinical pharmacology & therapeutics 90 (2), 246-255, 2011 | 195 | 2011 |
| Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2, 5-dimethoxy-substituted phenethylamines (2C drugs) A Rickli, D Luethi, J Reinisch, D Buchy, MC Hoener, ME Liechti Neuropharmacology 99, 546-553, 2015 | 193 | 2015 |
| Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018 | 191 | 2018 |
| Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study CM Hysek, LD Simmler, VG Nicola, N Vischer, M Donzelli, S Krähenbühl, ... PloS one 7 (5), e36476, 2012 | 191 | 2012 |
| Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics FG Revel, JL Moreau, RR Gainetdinov, A Ferragud, ... Biological psychiatry 72 (11), 934-942, 2012 | 166 | 2012 |
| Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity‐dependent neuronal plasticity O Griesbeck, M Canossa, G Campana, A Gärtner, MC Hoener, H Nawa, ... Microscopy research and technique 45 (4‐5), 262-275, 1999 | 150 | 1999 |
Matthias LiechtiUniversity Hospital BaselVerified email at usb.ch
